Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".

Abstract

BACKGROUND Patients with atrial fibrillation (AF) often take multiple medications. METHODS AND RESULTS We examined characteristics and compared adjusted outcomes between rivaroxaban and warfarin according to number of concomitant baseline medications and the presence of combined cytochrome P450 3A4 and P-glycoprotein inhibitors in the Rivaroxaban Once… (More)
DOI: 10.1161/CIRCULATIONAHA.115.018544

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.